arrow
M

M. Jachiet

universite paris cite
H指数:28
被引数:2,948

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Barrier-dominant lesional transcriptome associates with poor dupilumab response in prurigo nodularis

屏障主导的皮损转录组与结节性痒疹中度鲁单抗治疗反应不良相关

2026-10-290
PRE
Switching from intravenous to subcutaneous infliximab in hidradenitis suppurativa: a French multicenter retrospective study

将英夫利昔单抗从静脉注射转换为皮下注射治疗化脓性汗腺炎:一项法国多中心回顾性研究

2026-05-140
OAAI
Recommendations for the diagnostic work-up of cutaneous small vessel vasculitis - Position Statement of the European Academy of Dermatology and Venereology Vasculitis and Vasculopathy Task Force
2025-12-010
PRE
Impact of BMI and quality of life on dupilumab response in chronic prurigo: A cohort study

体重指数(BMI)和生活质量对慢性瘙痒性皮炎患者度普利尤单抗(dupilumab)疗效的影响:一项队列研究

2025-11-100
PRE
Treatment Strategies and Outcomes in Adult Relapsing or Refractory Cutaneous IgA Vasculitis: A Multicenter Retrospective Cohort Study

成人复发性或难治性皮肤IgA血管炎的治疗策略与结局:一项多中心回顾性队列研究

2025-11-060
PRE
Recommendations on management of adult-onset IgA vasculitis proposed by the European IgA vasculitis study group

欧洲IgA血管炎研究小组提出的成人IgA血管炎管理建议

2025-10-010
OAAI
Efficacy of anifrolumab in lupus erythematous panniculitis: A retrospective study of 11 patients

安普利单抗在红斑狼疮性脂膜炎中的疗效:一项11例患者的回顾性研究

2025-07-190
PRE
Single-Cell Profiling of Lichen Planus Reveals Type I IFN Response Triggering the Interface Dermatitis Reaction

银屑病单细胞分析揭示引发界面皮炎反应的I型干扰素应答

2025-06-090
PRE
Clinical, Histopathologic, and Molecular Features and Treatment of Multiple Xanthogranuloma in Adults

临床、组织病理学和分子特征及成人多发性黄色肉芽肿的治疗

2025-05-140
PRE
Inflammatory Signatures in VEXAS Syndrome, Myelodysplasia Cutis, and Sweet Syndrome

VEXAS综合征、骨髓增生异常相关皮肤病变和Sweet综合征中的炎症特征

2025-05-010
PRE
Favorable prognosis of subcutaneous sarcoidosis: French cohort of 80 patients compared with dermal sarcoidosis
2025-02-010
PRE
Switching From Dupilumab to Tralokinumab or Janus Kinase Inhibitors in Cases of Ocular and/or Facial Adverse Events in Patients With Atopic Dermatitis: A Multicenter Retrospective Study
2025-02-010
PRE